These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11250986)

  • 21. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary incontinence after treatment for localized prostate cancer.
    Krane RJ
    Mol Urol; 2000; 4(3):279-86;discussion 287. PubMed ID: 11062385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follow-up after therapy for prostate cancer. Treating the problems and caring for the man.
    Freedman A; Hahn G; Love N
    Postgrad Med; 1996 Sep; 100(3):125-9, 133-4, 136. PubMed ID: 8795650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
    Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
    Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life for men with prostate cancer.
    Katz A
    Cancer Nurs; 2007; 30(4):302-8. PubMed ID: 17666980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for prostate cancer: the case against.
    Hirst GH; Ward JE; Del Mar CB
    Med J Aust; 1996 Mar; 164(5):285-8. PubMed ID: 8628164
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.
    Miller DC; Sanda MG; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin WP; Wei JT
    J Clin Oncol; 2005 Apr; 23(12):2772-80. PubMed ID: 15837992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bother problems in prostate cancer patients after curative treatment.
    Stensvold A; Dahl AA; Brennhovd B; Småstuen MC; Fosså SD; Lilleby W; Steinsvik A; Axcrona K; Smeland S
    Urol Oncol; 2013 Oct; 31(7):1067-78. PubMed ID: 22341412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trial.
    Carlsson S; Aus G; Bergdahl S; Khatami A; Lodding P; Stranne J; Hugosson J
    Eur J Cancer; 2011 Mar; 47(4):545-53. PubMed ID: 21087857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and treatment of prostate cancer.
    Naitoh J; Zeiner RL; Dekernion JB
    Am Fam Physician; 1998 Apr; 57(7):1531-9, 1541-2, 1545-7. PubMed ID: 9556643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prostate cancer screening in the general population: the drawbacks are certain but the benefits are hypothetical].
    Aupérin A; Laplanche A; Hill C
    Presse Med; 2007; 36(7-8):1045-53. PubMed ID: 17482419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.
    Pardo Y; Guedea F; Aguiló F; Fernández P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Craven-Bratle J; Suárez JF; Boladeras A; Pont À; Ayala A; Sancho G; Martínez E; Alonso J; Ferrer M
    J Clin Oncol; 2010 Nov; 28(31):4687-96. PubMed ID: 20921463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PSA Screening for Prostate Cancer.
    Quaas J
    Am Fam Physician; 2015 May; 91(9):Online. PubMed ID: 25955746
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in continence and health-related quality of life after curative treatment and watchful waiting of prostate cancer.
    Katz G; Rodriguez R
    Urology; 2007 Jun; 69(6):1157-60. PubMed ID: 17572206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Radical prostatectomy--the optimal surgical treatment].
    Adding C; Nilsson A; Hosseini A; Carlsson S; Haendler L; Wiklund P
    Lakartidningen; 2012 Feb 22-28; 109(8):407-11. PubMed ID: 22509666
    [No Abstract]   [Full Text] [Related]  

  • 37. Is radical prostatectomy the "gold standard" for localized prostate cancer?
    Mendenhall WM; Nichols RC; Henderson R; Mendenhall NP
    Am J Clin Oncol; 2010 Oct; 33(5):511-5. PubMed ID: 20010078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Functional results and treatment of functional dysfunctions after radical prostatectomy].
    Salomon L; Droupy S; Yiou R; Soulié M
    Prog Urol; 2015 Nov; 25(15):1028-66. PubMed ID: 26519966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sexual rehabilitation and cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate cancer survivors.
    Chung E; Brock G
    J Sex Med; 2013 Feb; 10 Suppl 1():102-11. PubMed ID: 23387915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomes.
    Lennernäs B; Majumder K; Damber JE; Albertsson P; Holmberg E; Brandberg Y; Isacsson U; Ljung G; Damm O; Nilsson S
    Acta Oncol; 2015 Jun; 54(6):875-81. PubMed ID: 25362844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.